D. Western Therapeutics Institute, Inc. (4576.T)

D. Western Therapeutics Institute, Inc. (4576.T) — VMCI valuation read

D. Western Therapeutics Institute, Inc. sits at VMCI 26/100, with the Healthcare sector median at 50. That 24-point spread is the first thing to note on 4576.T: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on 4576.T are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on 4576.T: 4576.T trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%). The Risk read: net debt to EBITDA of 3.2x is the binding constraint on the bear case, anchoring the bear scenario on a measurable balance-sheet metric.

4576.T rose 0.8% over the trailing 7 days, with a +2.4% read on a 30-day basis.